← Back to screener

ACCENDRA HEALTH INC/VA/ ACH

Rank #1540 · NYSE · $0.0B market cap
Audited by KPMG, LLP, no going-concern flag in the latest filing.
Score
46.7
P/E
-0.5
P/B
0.02
ROE
-4.3%
Op. Margin
5.2%
Debt Ratio
421%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E -0.5x, P/B 0.02x. Ranks in the top 50% of the universe.

Profitability ★★☆☆☆
Weak

ROE -4.3%. Ranks in the top 65% of the universe.

Safety ★☆☆☆☆
Weak

Debt ratio 421%. Ranks in the top 77% of the universe. Above 200% signals meaningful leverage risk.

Growth ★☆☆☆☆
Poor

Revenue decline of 74.4% year over year. Ranks in the top 98% of the universe.

Valuation is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.2B$0.1B$0.9B–112
2012–$0.2B$0.1B$0.9B–112
2013–$0.2B$0.1B$1.0B–128
2014–$0.2B$0.1B$1.0B–127
2015–$0.2B$0.1B$1.0B–179
2016–$0.2B$0.1B$1.0B–174
2017–$0.2B$0.1B$1.0B–177
2018$9.7B$0.2B$0.1B$1.0B2.1238
2019$9.4B$-0.4B$-0.4B$1.0B-3.7321
2020$9.2B$0.1B$-0.1B$0.5B0.8614
2021$9.2B$0.1B$-0.1B$0.5B0.8506
2022$8.5B$0.2B$0.0B$0.5B2.4562
2023$9.8B$0.4B$0.2B$0.7B3.8624
2024$10.0B$0.1B$0.0B$0.9B1.4444
2025$2.6B$0.1B$-0.0B$1.0B5.2421

← See the full screener